Tender detail

Supply of Medicines and Medicinal Products II

Summary

The National Cancer Institute in Bratislava is procuring medicines and medicinal products for its hospital pharmacy over 24 months, divided into eight lots: carmustine formulations, cytostatic medicines, cabazitaxel, sacituzumab govitecan, avelumab, nivolumab with ipilimumab, and trastuzumab deruxtecan. The estimated total value is EUR 22,337,522.30. Delivery to the designated location, including unloading and packaging disposal, is part of the supply.

Reference number
691733-2026
Buyer
Národný onkologický ústav v Bratislave
Country
Slovakia (SVK)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-11-11
Status
Open
Contract subject
Supplies
Estimated value
22 337 522,30 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.